Bladder cancer, 1996

被引：64

作者：

Lamm, DL

Torti, FM

机构：

[1] Department of Urology, Robert C. Byrd Hlth. Sciences Center, West Virginia University, Morgantown, WV

[2] Department of Cancer Biology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC

来源：

CA-A CANCER JOURNAL FOR CLINICIANS | 1996年 / 46卷 / 02期

关键词：

D O I：

10.3322/canjclin.46.2.93

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Bladder cancer was one of the first cancers associated with workplace exposure to carcinogens, and although bladder cancer is largely preventable, its incidence is increasing in the United States. Treatment for bladder cancer has improved. Fewer patients require radical cystectomy as the primary treatment, bladder replacement procedures have improved, and more effective chemotherapy has been developed. This article reviews the epidemiology and etiology, clinical features, diagnosis, and treatment of bladder cancer.

引用

收藏

页码：93 / 112

页数：20

相关论文

共 105 条

[41] A RANDOMIZED TRIAL OF INTRAVESICAL DOXORUBICIN AND IMMUNOTHERAPY WITH BACILLE CALMETTE-GUERIN FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].

LAMM, DL ;

BLUMENSTEIN, BA ;

CRAWFORD, ED ;

MONTIE, JE ;

SCARDINO, P ;

GROSSMAN, HB ;

STANISIC, TH ;

SMITH, JA ;

SULLIVAN, J ;

SAROSDY, MF ;

CRISSMAN, JD ;

COLTMAN, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (17) :1205-1209

[42] APPARENT FAILURE OF CURRENT INTRAVESICAL CHEMOTHERAPY PROPHYLAXIS TO INFLUENCE THE LONG-TERM COURSE OF SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].

LAMM, DL ;

RIGGS, DR ;

TRAYNELIS, CL ;

NSEYO, UO .

JOURNAL OF UROLOGY, 1995, 153 (05) :1444-1450

[43]

LAMM DL, 1993, J UROLOGY, V149, pA282

[44]

LIGHT JK, 1986, UROL CLIN N AM, V13, P261

[45] ESCALATED DOSAGES OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN ADVANCED UROTHELIAL CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL [J].

LOEHRER, PJ ;

ELSON, P ;

DREICER, R ;

HAHN, R ;

NICHOLS, CR ;

WILLIAMS, R ;

EINHORN, LH .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :483-488

[46] A RANDOMIZED COMPARISON OF CISPLATIN ALONE OR IN COMBINATION WITH METHOTREXATE, VINBLASTINE, AND DOXORUBICIN IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA - A COOPERATIVE GROUP-STUDY [J].

LOEHRER, PJ ;

EINHORN, LH ;

ELSON, PJ ;

CRAWFORD, ED ;

KUEBLER, P ;

TANNOCK, I ;

RAGHAVAN, D ;

STUARTHARRIS, R ;

SAROSDY, MF ;

LOWE, BA ;

BLUMENSTEIN, B ;

TRUMP, D .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1066-1073

[47] ESCALATED THERAPY FOR REFRACTORY UROTHELIAL TUMORS - METHOTREXATE-VINBLASTINE-DOXORUBICIN-CISPLATIN PLUS UNGLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].

LOGOTHETIS, CJ ;

DEXEUS, FH ;

SELLA, A ;

AMATO, RJ ;

KILBOURN, RG ;

FINN, L ;

GUTTERMAN, JU .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (08) :667-672

[48] A PROSPECTIVE RANDOMIZED TRIAL COMPARING MVAC AND CISCA CHEMOTHERAPY FOR PATIENTS WITH METASTATIC UROTHELIAL TUMORS [J].

LOGOTHETIS, CJ ;

DEXEUS, FH ;

FINN, L ;

SELLA, A ;

AMATO, RJ ;

AYALA, AG ;

KILBOURN, RG .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1050-1055

[49] ADJUVANT CHEMOTHERAPY OF BLADDER-CANCER - A PRELIMINARY-REPORT [J].

LOGOTHETIS, CJ ;

JOHNSON, DE ;

CHONG, C ;

DEXEUS, FH ;

OGDEN, S ;

VONESCHENBACH, A ;

AYALA, A .

JOURNAL OF UROLOGY, 1988, 139 (06) :1207-1211

[50]

MALKOWICZ SB, 1990, UROLOGY, V36, P20

← 1 2 3 4 5 6 7 8 9 10 →